- Home
- SNTI vs TCBS Comparison
SNTI vs TCBS Comparison
Compare SNTI & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- TCBS
- Stock Information
- Founded
- SNTI 2016
- TCBS 1934
- Country
- SNTI United States
- TCBS United States
- Employees
- SNTI N/A
- TCBS N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- TCBS Banks
- Sector
- SNTI Health Care
- TCBS Finance
- Exchange
- SNTI Nasdaq
- TCBS Nasdaq
- Market Cap
- SNTI 53.6M
- TCBS 48.7M
- IPO Year
- SNTI N/A
- TCBS N/A
- Fundamental
- Price
- SNTI $1.91
- TCBS $15.90
- Analyst Decision
- SNTI Strong Buy
- TCBS
- Analyst Count
- SNTI 3
- TCBS 0
- Target Price
- SNTI $9.67
- TCBS N/A
- AVG Volume (30 Days)
- SNTI 292.3K
- TCBS 2.1K
- Earning Date
- SNTI 11-12-2025
- TCBS 11-17-2025
- Dividend Yield
- SNTI N/A
- TCBS 1.04%
- EPS Growth
- SNTI N/A
- TCBS N/A
- EPS
- SNTI N/A
- TCBS 0.79
- Revenue
- SNTI N/A
- TCBS $14,831,000.00
- Revenue This Year
- SNTI N/A
- TCBS N/A
- Revenue Next Year
- SNTI $150.00
- TCBS N/A
- P/E Ratio
- SNTI N/A
- TCBS $20.46
- Revenue Growth
- SNTI N/A
- TCBS 51.57
- 52 Week Low
- SNTI $1.26
- TCBS $14.79
- 52 Week High
- SNTI $16.94
- TCBS $19.40
- Technical
- Relative Strength Index (RSI)
- SNTI 49.03
- TCBS 43.01
- Support Level
- SNTI $1.92
- TCBS $16.05
- Resistance Level
- SNTI $2.29
- TCBS $16.18
- Average True Range (ATR)
- SNTI 0.16
- TCBS 0.06
- MACD
- SNTI -0.03
- TCBS -0.02
- Stochastic Oscillator
- SNTI 0.00
- TCBS 0.00
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.